Defining drivers of under-immunization and vaccine hesitancy in refugee and migrant populations.
COVID-19 vaccines
migrants
refugees
vaccination
vaccine hesitancy
vaccine uptake
Journal
Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456
Informations de publication
Date de publication:
05 09 2023
05 09 2023
Historique:
received:
13
04
2023
revised:
15
05
2023
accepted:
29
05
2023
medline:
7
9
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
Some refugee and migrant populations globally showed lower uptake of COVID-19 vaccines and are also considered to be an under-immunized group for routine vaccinations. These communities may experience a range of barriers to vaccination systems, yet there is a need to better explore drivers of under-immunization and vaccine hesitancy in these mobile groups. We did a global rapid review to explore drivers of under-immunization and vaccine hesitancy to define strategies to strengthen both COVID-19 and routine vaccination uptake, searching MEDLINE, Embase, Global Health PsycINFO and grey literature. Qualitative data were analysed thematically to identify drivers of under-immunization and vaccine hesitancy, and then categorized using the 'Increasing Vaccination Model'. Sixty-three papers were included, reporting data on diverse population groups, including refugees, asylum seekers, labour migrants and undocumented migrants in 22 countries. Drivers of under-immunization and vaccine hesitancy pertaining to a wide range of vaccines were covered, including COVID-19 (n = 27), human papillomavirus (13), measles or Measles-mumps-rubella (MMR) (3), influenza (3), tetanus (1) and vaccination in general. We found a range of factors driving under-immunization and hesitancy in refugee and migrant groups, including unique awareness and access factors that need to be better considered in policy and service delivery. Acceptability of vaccination was often deeply rooted in social and historical context and influenced by personal risk perception. These findings hold direct relevance to current efforts to ensure high levels of global coverage for a range of vaccines and to ensure that marginalized refugee and migrant populations are included in the national vaccination plans of low-, middle- and high-income countries. We found a stark lack of research from low- and middle-income and humanitarian contexts on vaccination in mobile groups. This needs to be urgently rectified if we are to design and deliver effective programmes that ensure high coverage for COVID-19 and routine vaccinations.
Sections du résumé
BACKGROUND/OBJECTIVE
Some refugee and migrant populations globally showed lower uptake of COVID-19 vaccines and are also considered to be an under-immunized group for routine vaccinations. These communities may experience a range of barriers to vaccination systems, yet there is a need to better explore drivers of under-immunization and vaccine hesitancy in these mobile groups.
METHODS
We did a global rapid review to explore drivers of under-immunization and vaccine hesitancy to define strategies to strengthen both COVID-19 and routine vaccination uptake, searching MEDLINE, Embase, Global Health PsycINFO and grey literature. Qualitative data were analysed thematically to identify drivers of under-immunization and vaccine hesitancy, and then categorized using the 'Increasing Vaccination Model'.
RESULTS
Sixty-three papers were included, reporting data on diverse population groups, including refugees, asylum seekers, labour migrants and undocumented migrants in 22 countries. Drivers of under-immunization and vaccine hesitancy pertaining to a wide range of vaccines were covered, including COVID-19 (n = 27), human papillomavirus (13), measles or Measles-mumps-rubella (MMR) (3), influenza (3), tetanus (1) and vaccination in general. We found a range of factors driving under-immunization and hesitancy in refugee and migrant groups, including unique awareness and access factors that need to be better considered in policy and service delivery. Acceptability of vaccination was often deeply rooted in social and historical context and influenced by personal risk perception.
CONCLUSIONS
These findings hold direct relevance to current efforts to ensure high levels of global coverage for a range of vaccines and to ensure that marginalized refugee and migrant populations are included in the national vaccination plans of low-, middle- and high-income countries. We found a stark lack of research from low- and middle-income and humanitarian contexts on vaccination in mobile groups. This needs to be urgently rectified if we are to design and deliver effective programmes that ensure high coverage for COVID-19 and routine vaccinations.
Identifiants
pubmed: 37335192
pii: 7202018
doi: 10.1093/jtm/taad084
pmc: PMC10481413
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MRC/N013638/1
Pays : United Kingdom
Organisme : Academy of Medical Sciences
ID : SBF005\1111
Pays : United Kingdom
Informations de copyright
© International Society of Travel Medicine 2023. Published by Oxford University Press.
Références
J Transcult Nurs. 1999 Jul;10(3):229-36
pubmed: 10693410
Vaccine. 2016 Sep 22;34(41):5013-5020
pubmed: 27576074
Reprod Health. 2016 Aug 22;13(1):97
pubmed: 27549328
J Migr Health. 2021;3:100041
pubmed: 33903857
Euro Surveill. 2019 Jul;24(27):
pubmed: 31290391
BMC Public Health. 2015 Dec 10;15:1229
pubmed: 26654538
Vaccine. 2019 May 6;37(20):2741-2747
pubmed: 30979570
Hum Vaccin Immunother. 2019;15(7-8):1697-1707
pubmed: 30352005
Br J Gen Pract. 2021 Jul 29;71(709):e583-e595
pubmed: 33875420
Health Expect. 2021 Aug;24(4):1158-1167
pubmed: 33942948
J Travel Med. 2023 Feb 18;30(1):
pubmed: 34195828
Public Health. 2011 Aug;125(8):505-11
pubmed: 21802701
Lancet. 2022 Nov;400 Suppl 1:S5
pubmed: 36929995
Prev Med Rep. 2021 Dec;24:101606
pubmed: 34692378
Brain Behav Immun. 2021 May;94:41-50
pubmed: 33713824
Prev Med Rep. 2018 Feb 23;10:93-99
pubmed: 29868358
Anthropol Med. 2021 Dec;28(4):411-419
pubmed: 33183060
Health Promot Int. 2019 Oct 1;34(5):e36-e46
pubmed: 30189003
Ind Health. 2016 Dec 7;54(6):554-563
pubmed: 27251030
J Immigr Minor Health. 2016 Oct;18(5):1060-1065
pubmed: 26001843
Womens Health Issues. 2015 Mar-Apr;25(2):112-9
pubmed: 25747518
Vaccine. 2018 Jul 25;36(31):4687-4692
pubmed: 29945834
Health Expect. 2015 Jun;18(3):344-54
pubmed: 23252449
Health Policy Technol. 2022 Jun;11(2):100606
pubmed: 35194550
Am J Trop Med Hyg. 2021 Jan 13;104(2):433-435
pubmed: 33534734
Int J Health Policy Manag. 2016 May 08;5(10):589-597
pubmed: 27694650
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Influenza Other Respir Viruses. 2021 May;15(3):361-370
pubmed: 33605010
J Immigr Minor Health. 2022 Aug;24(4):896-908
pubmed: 35212825
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Int J Environ Res Public Health. 2018 Nov 01;15(11):
pubmed: 30388799
Vaccines (Basel). 2021 May 07;9(5):
pubmed: 34067103
Educ Health (Abingdon). 2011 Dec;24(3):479
pubmed: 22267344
Vaccine. 2011 Jun 10;29(26):4405-8
pubmed: 21501645
BMC Public Health. 2020 Mar 23;20(1):381
pubmed: 32293379
Lancet Infect Dis. 2021 Dec;21(12):e387-e398
pubmed: 34626552
Euro Surveill. 2018 Oct;23(41):
pubmed: 30326996
J Migr Health. 2021;4:100050
pubmed: 34075367
Eur J Pediatr. 2020 Jan;179(1):171-175
pubmed: 31701239
Public Health Rev. 2016 Oct 3;37:13
pubmed: 29450055
Trop Med Infect Dis. 2020 Apr 09;5(2):
pubmed: 32283644
PLoS One. 2019 Dec 26;14(12):e0226948
pubmed: 31877563
J Migr Health. 2022;5:100086
pubmed: 35194589
BMC Public Health. 2021 Jan 7;21(1):93
pubmed: 33413287
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Int J Environ Res Public Health. 2022 Jan 10;19(2):
pubmed: 35055541
PLoS One. 2014 Oct 15;9(10):e108261
pubmed: 25330079
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
BMJ Open. 2022 Mar 17;12(3):e056591
pubmed: 35301211
Vaccine. 2020 Mar 17;38(13):2795-2799
pubmed: 32089460
J Community Health. 2022 Jun;47(3):530-538
pubmed: 35325337
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Cancer Educ. 2017 Sep;32(3):516-521
pubmed: 26687173
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33772312
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
BMJ Open. 2020 May 12;10(5):e035225
pubmed: 32404392
J Travel Med. 2022 Sep 17;29(6):
pubmed: 35417000
Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593
pubmed: 32693678
Vaccine. 2019 Feb 4;37(6):833-838
pubmed: 30642728
Vaccines (Basel). 2021 May 02;9(5):
pubmed: 34063182
BMC Public Health. 2021 Apr 7;21(1):668
pubmed: 33827509
Curr Opin Immunol. 2021 Aug;71:62-68
pubmed: 34118728
BMJ Open. 2019 Jul 9;9(7):e028228
pubmed: 31289079
J Travel Med. 2020 Nov 9;27(7):
pubmed: 32706375
BMJ. 2021 Feb 26;372:n513
pubmed: 33637577
Br J Gen Pract. 2019 Aug;69(685):e537-e545
pubmed: 30745354
Acad Pediatr. 2021 May-Jun;21(4S):S9-S16
pubmed: 33958099
Lancet Reg Health Eur. 2021 Jul;6:100147
pubmed: 34124708
EClinicalMedicine. 2021 May;35:100860
pubmed: 34027328
J Infect Dev Ctries. 2019 Dec 31;13(12):1159-1164
pubmed: 32088704
Public Health. 2019 Jun;171:97-105
pubmed: 31121558
Eur J Public Health. 2018 Feb 1;28(1):82-87
pubmed: 29240907
Pediatrics. 2014 Jul;134(1):e220-8
pubmed: 24913790
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389